OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAFV600E Dual Inhibitors Endowed with Antiproliferative Activity
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Alaa A. Hassan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 7
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Alaa A. Hassan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 7
Showing 7 citing articles:
Design and Synthesis of New Dihydropyrimidine Derivatives with a Cytotoxic Effect as Dual EGFR/VEGFR-2 Inhibitors
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Lamya H. Al-Wahaibi, Ali M. Elshamsy, Taha F. S. Ali, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34358-34369
Open Access | Times Cited: 9
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access
Design, Synthesis of 3‐(Aryl)‐1‐(2‐p‐tolylthiazol‐4‐yl)prop‐2‐en‐1‐ones as Alpha(α)‐Amylase Inhibitors
Hafsa Iqbal, Muhammad Haroon, Tashfeen Akhtar, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 9
Closed Access
Hafsa Iqbal, Muhammad Haroon, Tashfeen Akhtar, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 9
Closed Access
Novel Thiazole-Hydrazide Derivatives and Their Anticancer Properties
Asaf Evrim Evren, Demokrat Nuha, Sam Dawbaa, et al.
Clinical and Experimental Health Sciences (2024)
Open Access
Asaf Evrim Evren, Demokrat Nuha, Sam Dawbaa, et al.
Clinical and Experimental Health Sciences (2024)
Open Access
Design, Synthesis, In Silico Studies, and Anticancer Activity of Novel Nitrobenzene Thiazolyl Hydrazones against the EGFR
Sonali Shinde, Jaydeo T. Kilbile, Shankar Thapa, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 6, pp. 2483-2498
Closed Access
Sonali Shinde, Jaydeo T. Kilbile, Shankar Thapa, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 6, pp. 2483-2498
Closed Access
Special Issue “Novel Anti-Proliferative Agents”
Valentina Onnis
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1437-1437
Open Access
Valentina Onnis
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1437-1437
Open Access
